Press release
LIVER CIRRHOSIS DRUG MARKET 2020 RISING TREND INCLUDING KEY PLAYERS PROFILE LIKE GILEAD SCIENCES, INC., INTERCEPT PHARMACEUTICALS, INC., DOVA PHARMACEUTICALS
Global Liver Cirrhosis Drug Market
Market Analysis:
Global liver cirrhosis drugs market is rise gradually to an estimated value of USD 66.01 Billion by 2026 registering a CAGR of 10.5% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.
GET SAMPLE REPORT + ALL RELATED GRAPHS & CHARTS @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-liver-cirrhosis-drugs-market
Key Market Players: Global Liver Cirrhosis Drug Market
Few of the major competitors currently working in the global liver cirrhosis drug market are, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc., Dova Pharmaceuticals, GlaxoSmithKline Plc, Regeneron Pharmaceuticals, Mylan N.V, Sanofi S.A, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd, Boehringer Ingelheim International GmbH, Sunovion Pharmaceuticals Inc., Merck & Co., Inc., Eli Lilly and Company, AbbVie Inc and among others.
Competitive Analysis: Global Liver Cirrhosis Drug Market
Global liver cirrhosis drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of liver cirrhosis drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Definition: Global Liver Cirrhosis Drug Market
Liver Cirrhosis is chronic injury to the liver which results in damage or liver might stop functioning due to chronic consumption of alcohol products, long term liver infection, defects in immune system and obesity etc. Liver cirrhosis develops slowly and it takes many years to develop. The patient with liver cirrhosis disease experience tiredness or unwell, loss of appetite, abdominal pain, white nail, dark urine and disturbed sleep pattern.
According to the survey report published BMJ Publishing Group Ltd, it is identified that from the year 1999 to 2016 in the United States the annual cirrhosis dead rate is increases by 65% to over 34174. The increase in prevalence of liver diseases, chronic consumption of alcohol and adoption of unhealthy diet are the factors contributing to rise in liver cirrhosis drugs market.
Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-liver-cirrhosis-drugs-market
Key Developments in the Market:
In May 2018, Dova Pharmaceuticals received the FDA approval Doptelet (avatrombopag), which previously received priority review for the treatment of the thrombocytopenia in adult patients with chronic liver disease (CLD). Doptelet is thrombopoietin receptor agonists which regulates the normal platelet production.
In May 2016, Intercept Pharmaceuticals, Inc. received FDA accelerated approval for Ocaliva alone or, in combination with ursodeoxycholic acid for patient who are unable to tolerate ursodeoxycholic acid for the treatment of primary biliary cholangitis (PBC).
Market Drivers
Increase in prevalence rate of Liver Cirrhosis Disease
Exposure to certain toxin or change in environment may increase the Liver Cirrhosis disease.
Chronic consumption of tobacco smoke and alcohol.
Patient who have experienced a long term long-term Hepatitis B or Hepatitis C infection.
Patient who are clinically over- weight and have fatty liver.
Rising awareness about treatment and technological advancement is driving the growth of market.
Increase in the rate of R&D initiatives is driving Liver Cirrhosis disease drug
Market Restraints
Effective treatment is either unavailable or unaffordable.
Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market.
Lack of awareness among the patient and physician about Liver Cirrhosis disease
Get Free Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-liver-cirrhosis-drugs-market
Segmentation: Global Liver Cirrhosis Drug Market
By Site of Origin Type
Hepatitis C-related Cirrhosis
Alcoholic Cirrhosis
Primary Sclerosing Cholangitis
Primary Biliary Cirrhosis
Others
By Stage Type
Compensated cirrhosis
Decompensated cirrhosis
By Drug Type
Ursodeoxycholic acid
Obeticholic acid
Azathioprine
Colchicine
Others
By Therapy
Medication
Healthy Diet
Surgery
Weight loss
Others
By Route of administration
Oral
Intravenous
Others
By End users
Hospitals
Homecare
Specialty Clinics
Others
Reasons to Purchase this Report
Current and future of global liver cirrhosis drugs market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release LIVER CIRRHOSIS DRUG MARKET 2020 RISING TREND INCLUDING KEY PLAYERS PROFILE LIKE GILEAD SCIENCES, INC., INTERCEPT PHARMACEUTICALS, INC., DOVA PHARMACEUTICALS here
News-ID: 1962419 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Cirrhosis
Cirrhosis Pipeline: Novel Antifibrotic Therapies and Regenerative Approaches Red …
The treatment landscape for cirrhosis, a progressive liver condition marked by fibrosis and compromised liver function, is witnessing a transformative shift as biopharmaceutical companies advance beyond symptomatic management to target the underlying causes of liver damage. With no approved therapies to reverse established fibrosis, there is a growing focus on antifibrotic agents, hepatoprotective compounds, and regenerative therapies that aim to halt or reverse disease progression. Companies like Ocera Therapeutics, Gilead…
Liver Cirrhosis - Drug Pipeline Landscape, 2023
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis and end-stage liver disease, is a condition characterised by impaired liver function caused by the formation of scar tissue known as fibrosis as a result of liver disease damage. Cirrhosis is caused by alcoholic liver disease, non-alcoholic steatohepatitis (NASH), chronic hepatitis B, and chronic hepatitis C.
To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS31149
Cirrhosis symptoms emerge slowly until liver…
Primary Biliary Cirrhosis - Drug Pipeline Landscape, 2023
New York, Global Insight Services have recently published a report on Primary Biliary Cirrhosis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Read more about Primary Biliary Cirrhosis - Drug Pipeline here: https://www.globalinsightservices.com/reports/primary-biliary-cirrhosis-primary-biliary-cholangitis-drug-pipeline-landscape-2022/
Primary Biliary Cirrhosis (Primary Biliary Cholangitis) is a chronic disease in which the small bile ducts in the liver become injured and inflamed…
Liver Cirrhosis - Drug Pipeline Landscape, 2023
New York, Global Insight Services have recently published a report on Liver Cirrhosis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Read more about this report: https://www.globalinsightservices.com/reports/liver-cirrhosis-drug-pipeline-landscape-2023/
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis and end-stage liver disease, is a condition characterised by impaired liver function caused by the formation of scar tissue known…
Primary Biliary Cirrhosis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Primary Biliary Cirrhosis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Primary Biliary Cirrhosis (Primary Biliary Cholangitis) is a chronic disease in which the small bile ducts in the liver become injured and inflamed and are destroyed eventually.
Read more about Primary Biliary Cirrhosis - Drug Pipeline…
Global Liver Cirrhosis Market Growth 2018-2023
Market Research Report Store offers a latest published report on Liver Cirrhosis Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Liver Cirrhosis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Liver Cirrhosis with respect to individual…
